87 related articles for article (PubMed ID: 22785053)
1. Generation of human bronchial epithelial cell lines expressing inactive mutants of GALNT3.
Nakamura S; Horie M; Fujino K; Matsumoto Y; Honda T; Tomonaga K
J Vet Med Sci; 2012 Nov; 74(11):1493-6. PubMed ID: 22785053
[TBL] [Abstract][Full Text] [Related]
2. Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.
Nakamura S; Horie M; Daidoji T; Honda T; Yasugi M; Kuno A; Komori T; Okuzaki D; Narimatsu H; Nakaya T; Tomonaga K
J Virol; 2016 Feb; 90(4):1788-801. PubMed ID: 26637460
[TBL] [Abstract][Full Text] [Related]
3. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
[TBL] [Abstract][Full Text] [Related]
4. Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.
Peluso G; Tian E; Abusleme L; Munemasa T; Mukaibo T; Ten Hagen KG
J Biol Chem; 2020 Jan; 295(5):1411-1425. PubMed ID: 31882545
[TBL] [Abstract][Full Text] [Related]
5. GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells.
Raghu D; Mobley RJ; Shendy NAM; Perry CH; Abell AN
Cell Rep; 2019 Mar; 26(13):3684-3697.e7. PubMed ID: 30917321
[TBL] [Abstract][Full Text] [Related]
6. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.
Sheta R; Woo CM; Roux-Dalvai F; Fournier F; Bourassa S; Droit A; Bertozzi CR; Bachvarov D
J Proteomics; 2016 Aug; 145():91-102. PubMed ID: 27095597
[TBL] [Abstract][Full Text] [Related]
7. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.
Topaz O; Shurman DL; Bergman R; Indelman M; Ratajczak P; Mizrachi M; Khamaysi Z; Behar D; Petronius D; Friedman V; Zelikovic I; Raimer S; Metzker A; Richard G; Sprecher E
Nat Genet; 2004 Jun; 36(6):579-81. PubMed ID: 15133511
[TBL] [Abstract][Full Text] [Related]
8. The participation of ribosome-UDP-GalNAc complex in the initiation of protein glycosylation in vitro.
Paszkiewicz-Gadek A; Porowska H; Gindzieński A
Acta Biochim Pol; 2000; 47(2):421-6. PubMed ID: 11051206
[TBL] [Abstract][Full Text] [Related]
9. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
[TBL] [Abstract][Full Text] [Related]
10. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation.
Clausen H; Bennett EP
Glycobiology; 1996 Sep; 6(6):635-46. PubMed ID: 8922959
[No Abstract] [Full Text] [Related]
11. Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.
Yoshida CA; Kawane T; Moriishi T; Purushothaman A; Miyazaki T; Komori H; Mori M; Qin X; Hashimoto A; Sugahara K; Yamana K; Takada K; Komori T
J Biol Chem; 2014 Sep; 289(38):26584-26596. PubMed ID: 25107907
[TBL] [Abstract][Full Text] [Related]
12. A mouse with an N-Ethyl-N-nitrosourea (ENU) Induced Trp589Arg Galnt3 mutation represents a model for hyperphosphataemic familial tumoural calcinosis.
Esapa CT; Head RA; Jeyabalan J; Evans H; Hough TA; Cheeseman MT; McNally EG; Carr AJ; Thomas GP; Brown MA; Croucher PI; Brown SD; Cox RD; Thakker RV
PLoS One; 2012; 7(8):e43205. PubMed ID: 22912827
[TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome.
Olauson H; Krajisnik T; Larsson C; Lindberg B; Larsson TE
Eur J Endocrinol; 2008 Jun; 158(6):929-34. PubMed ID: 18322299
[TBL] [Abstract][Full Text] [Related]
14. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
15. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
16. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
Schjoldager KT; Clausen H
Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
[TBL] [Abstract][Full Text] [Related]
17. High level in vivo mucin-type glycosylation in Escherichia coli.
Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S
Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
[TBL] [Abstract][Full Text] [Related]
19. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Casaravilla C; Freire T; Malgor R; Medeiros A; Osinaga E; Carmona C
J Parasitol; 2003 Aug; 89(4):709-14. PubMed ID: 14533679
[TBL] [Abstract][Full Text] [Related]
20. GALNT3 inhibits NF-κB signaling during influenza A virus infection.
Wang B; Zhang Y; Jiang W; Zhu L; Li K; Zhou K; Dai D; Chang S; Fang M
Biochem Biophys Res Commun; 2018 Sep; 503(4):2872-2877. PubMed ID: 30100058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
